Myotonia is a condition where muscles struggle to relax after they contract, leading to stiffness, cramping, and discomfort that can affect daily activities. Understanding the available treatments and the research underway can help people living with myotonia manage their symptoms and maintain quality of life.

How Doctors Approach Myotonia Treatment Today

When someone receives a diagnosis of myotonia, the treatment plan focuses on several key goals. The first priority is managing the muscle stiffness and delayed relaxation that defines this condition. Doctors work to reduce the impact of myotonia, which is the inability of muscles to quickly relax after voluntary contraction, on a person’s daily life. This might mean helping someone release their grip on a door handle without difficulty, or allowing them to walk without the stiffness that can develop after rest.^[1]

Treatment approaches vary significantly depending on which type of myotonia a person has. There are two main categories: dystrophic myotonias, which include myotonic dystrophy types 1 and 2, and non-dystrophic myotonias, such as myotonia congenita and paramyotonia congenita. Each form responds differently to treatment, and what works for one person may not work for another. Medical teams consider the disease stage, severity of symptoms, and how much the condition interferes with work, school, or social activities when designing a treatment plan.^[1][2]

The medical community has established guidelines and recommendations based on clinical experience and available research, though it’s important to note that many treatment strategies are based more on clinical consensus than on large-scale randomized controlled trials. This means that doctors often rely on their experience with many patients, along with smaller studies, to guide their treatment decisions. Research into new therapies continues, with clinical trials testing innovative approaches that may one day become standard treatments.^[12]

Standard Treatments Used Today

For many people with myotonia, especially those with non-dystrophic forms, managing symptoms begins with understanding and avoiding triggers. Cold temperatures can worsen muscle stiffness in many types of myotonia, so staying warm and avoiding sudden exposure to cold environments becomes part of daily management. Some individuals with certain types of myotonia, particularly sodium channel myotonia and periodic paralyses, find that their symptoms respond to dietary changes, such as reducing foods high in potassium.^[20]

Physical activity plays an important but nuanced role in managing myotonia. For many people, a phenomenon called the “warm-up effect” occurs, where muscle stiffness improves after muscles have been used for a few repetitions. This means that while the first movements after rest may be difficult, continuing to move can actually help. Healthcare providers often recommend moderate aerobic exercise like swimming, cycling, or walking. Resistance training is generally considered safe, though sudden forceful contractions should be avoided. It’s crucial to warm up gradually, take rest periods when needed, and cool down slowly after exercise.^[3][20]

Medication Options

When lifestyle modifications aren’t enough, medications can help reduce muscle stiffness and improve function. The most commonly used and studied medication is mexiletine, a sodium channel blocker. This drug works by stabilizing the electrical activity in muscle cell membranes, helping muscles relax more normally after contraction. Mexiletine has shown the most evidence of benefit among available treatments, particularly for non-dystrophic myotonia, and appears to also provide some benefit for people with myotonic dystrophy, though the effect may be smaller.^[11][14]

The most common side effects of mexiletine include heartburn or reflux (a burning sensation in the chest caused by stomach acid) and headache. These effects are generally manageable, and many people tolerate the medication well. However, because mexiletine affects heart rhythm, doctors monitor patients carefully when starting this treatment.^[11]

Other medications used to treat myotonia include anticonvulsant drugs such as phenytoin, carbamazepine, and lamotrigine. These medications also work by affecting the electrical signals in muscles. Lamotrigine in particular has shown promise in clinical studies, with evidence suggesting it may reduce myotonia in people with non-dystrophic myotonia. Common side effects of lamotrigine include headache, skin rash and itching, and fatigue.^[11][15]

Older treatments that are now used less frequently include quinine, which was once popular but is rarely prescribed now due to side effects, and the antidepressants clomipramine and imipramine. Small studies suggested these tricyclic antidepressants might help, though the evidence was limited. Another medication called procainamide has also been used.^[7][10]

The duration of medication treatment varies by individual. Some people need continuous treatment to maintain muscle function, while others may use medications only during periods when symptoms are particularly bothersome. Doctors typically start with lower doses and adjust based on how well symptoms improve and whether side effects occur. Regular follow-up appointments allow the medical team to monitor effectiveness and make necessary adjustments.^[13]

Rehabilitation and Supportive Therapies

Beyond medications, rehabilitative therapies play a vital role in managing myotonia. Physical therapy helps maintain muscle strength and flexibility while teaching safe ways to exercise that don’t trigger severe stiffness. Occupational therapy can be particularly valuable for people whose myotonia affects hand function and daily tasks. Therapists can recommend adaptive equipment and strategies to make activities easier.^[13]

For people with myotonic dystrophy, which affects multiple body systems beyond muscles, additional supportive care becomes necessary. This might include speech therapy for swallowing or pronunciation difficulties, psychiatric support for behavioral or psychological issues such as attention problems or depression, and specialized educational support for children with learning difficulties.^[13]

Assistive devices can significantly improve mobility and independence. Depending on individual needs, this might include neck braces, arm or foot braces, canes, walkers, scooters, or wheelchairs. For people with droopy eyelids (a condition called ptosis), special eye supports called “eye crutches” can help. Those with heart rhythm problems may need a pacemaker or implantable cardioverter defibrillator (ICD), a device that monitors and corrects dangerous heart rhythms.^[13]

Treatments Being Tested in Clinical Trials

While current treatments can help manage symptoms, they don’t address the underlying genetic causes of myotonia or slow disease progression. This has driven researchers to explore new therapeutic approaches in clinical trials. These studies test innovative molecules and treatment strategies that might offer better symptom control or, potentially, modify the course of the disease itself.

Understanding Clinical Trial Phases

Clinical trials typically progress through three phases before a treatment can be approved for general use. Phase I trials primarily test safety, usually involving small numbers of healthy volunteers or patients to determine appropriate dosing and identify potential side effects. Phase II trials expand to larger groups of patients to evaluate whether the treatment actually improves symptoms or disease markers while continuing to monitor safety. Phase III trials compare the new treatment against current standard treatments or placebo in even larger patient populations, often involving hundreds or thousands of participants across multiple locations. These trials provide the evidence needed for regulatory approval.^[11]

Current Research Directions

Most recent clinical trial activity in myotonia has focused on refining and expanding the use of existing medications like mexiletine and lamotrigine. Researchers have conducted better-designed studies to more definitively establish how well these medications work. Several studies published in recent years have provided stronger evidence that mexiletine is both safe and effective for non-dystrophic myotonia, and likely provides some benefit for myotonic dystrophy as well. Similar studies have explored lamotrigine’s potential.^[11]

The research landscape for myotonia remains challenging because these conditions are relatively rare. This makes it difficult to recruit large numbers of participants for clinical trials. Studies often involve multiple countries and medical centers to gather sufficient participants. Trials have been conducted in the United States, various European countries including the Netherlands, Germany, and France, and other locations worldwide. Eligibility criteria vary by study but typically include confirmed genetic diagnosis, specific age ranges, and a certain level of symptom severity.^[11]

Preliminary results from recent trials have shown measurable improvements in clinical parameters. For example, studies measuring muscle stiffness using objective tests called electromyography (EMG), which records electrical activity in muscles, have documented reduced abnormal activity after treatment. Patients have reported subjective improvements in their ability to perform daily activities, reduced muscle pain, and less disability from stiffness. Safety profiles have generally been positive, with most people tolerating the medications reasonably well.^[11]

Looking beyond traditional medications, researchers are exploring more fundamental approaches. Some scientists are investigating treatments that might address the abnormal gene products that cause myotonia, though these approaches remain in earlier stages of development. The molecular mechanisms of myotonia are now better understood than ever before. Scientists know that myotonia results from defects in ion channels, which are proteins in muscle cell membranes that control the flow of electrically charged particles like sodium, chloride, and potassium. Different genetic mutations affect different channels, but they all disrupt the normal electrical regulation that allows muscles to contract and relax smoothly.^[1][5]

This understanding has led researchers to explore whether targeting specific ion channels or the cellular pathways affected by abnormal gene products might lead to new treatments. While no gene therapies or highly targeted molecular treatments have yet reached clinical trials for myotonia, the groundwork is being laid through laboratory research. Patient registries, which collect information from many people with myotonia worldwide, are helping researchers better understand the natural history of these conditions and identify which outcomes matter most to patients, information crucial for designing future trials.^[13]

Most common treatment methods

• Lifestyle modifications
  • Avoiding cold temperatures and sudden temperature changes to prevent triggering muscle stiffness
  • Dietary adjustments, particularly reducing potassium-rich foods for certain types of myotonia like sodium channel myotonia and periodic paralyses
  • Warming up gradually before physical activity and cooling down slowly afterward
  • Taking advantage of the “warm-up phenomenon” where muscle stiffness improves with repeated movement
• Exercise therapy
  • Moderate aerobic exercise such as swimming, cycling, and walking to improve overall fitness
  • Resistance training while avoiding sudden forceful contractions
  • Physical therapy to maintain muscle strength and flexibility safely
  • Avoiding exercise in cold temperatures or cool water
• Sodium channel blockers
  • Mexiletine, the most studied and effective medication, which stabilizes muscle cell electrical activity
  • Works by helping muscles relax normally after contraction
  • Particularly effective for non-dystrophic myotonia, with some benefit for myotonic dystrophy
  • Common side effects include heartburn and headache
• Anticonvulsant medications
  • Lamotrigine, which has shown promise in reducing myotonia symptoms
  • Phenytoin and carbamazepine, used to affect electrical signals in muscles
  • Side effects may include headache, skin rash, and fatigue
• Rehabilitative services
  • Physical therapy for maintaining muscle function and teaching safe exercise techniques
  • Occupational therapy for adapting daily activities and recommending assistive devices
  • Speech therapy for people experiencing swallowing or pronunciation difficulties
  • Psychiatric therapy for managing behavioral and psychological issues like attention deficit and depression
• Assistive devices and medical equipment
  • Mobility aids including neck braces, arm and foot braces, canes, walkers, scooters, and wheelchairs
  • Eye supports for managing droopy eyelids
  • Pacemakers or implantable cardioverter defibrillators for people with heart rhythm problems

Living with Myotonia: Daily Management

Living with myotonia requires ongoing attention to symptom management and regular medical monitoring. Because myotonia can affect multiple body systems, especially in dystrophic forms, people benefit from working with a team of healthcare providers. This might include a neurologist specializing in neuromuscular diseases, a cardiologist for heart monitoring, a pulmonologist for breathing concerns, and various therapists. Coordination among these specialists ensures comprehensive care.^[12][16]

The impact of myotonia extends beyond physical symptoms. Many people experience fatigue that goes beyond what would be expected from the muscle problems alone. This can affect work, school, and social life. Some individuals with myotonic dystrophy experience excessive daytime sleepiness due to abnormalities in the parts of the brain that regulate sleep and wakefulness. Others describe a sense of overall apathy or reduced cognitive function that may relate to changes in the brain caused by the disease. Understanding these aspects helps families and employers provide appropriate support.^[6][18]

The variability of myotonia, both in which symptoms develop and how severe they become, means that predicting an individual’s future can be difficult. Some people have only mild stiffness and cataracts late in life, while others face more significant challenges. This uncertainty can be emotionally difficult. Connecting with support groups, either in person or online, allows people to share experiences and practical strategies. Many find that talking with others who truly understand what living with myotonia is like provides valuable emotional support and practical advice.^[16]